reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD012342-bib-0001,NCT01615146. ,Outpatient platelet transfusions in myelodysplastic syndromes and leukemia: The OPTIMAL pilot (OPTIMAL),,,,   ,['citation-other'], NCT01615146. Outpatient platelet transfusions in myelodysplastic syndromes and leukemia: The OPTIMAL pilot (OPTIMAL). clinicaltrials.gov/ct2/show/NCT01615146 (first received 6 June 2012). CENTRAL    ,[''],,, NCT01615146 {published data only}  ,included,CD012342-bbs2-0001,
CD012342-bib-0002,"Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, et al. ",A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants, Journal of Pediatrics ,1993,123,    ,['citation-journal']," Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, et al. A randomized controlled trial of platelet transfusions in thrombocytopenic premature infants.  Journal of Pediatrics 1993;123(2):285–91. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0022-3476(05)81705-6', 'https://www.ncbi.nlm.nih.gov/pubmed/8345429', 'https://scholar.google.com/scholar_lookup?title=A+randomized+controlled+trial+of+platelet+transfusions+in+thrombocytopenic+premature+infants+&author=M+Andrew&author=P+Vegh&author=C+Caco&author=H+Kirpalani&author=A+Jefferies&author=A+Ohlsson&publication_year=1993&hl=en']",8345429,https://doi.org/10.1016/S0022-3476(05)81705-6, Andrew 1993 {published data only}  ,excluded,CD012342-bbs2-0002, Wrong population ‐ premature infants 
CD012342-bib-0003,"Ferrara M, Capozzi L, Coppola A, Save G, Coppola L. ",Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review, Hematology ,2007,12,    ,['citation-journal']," Ferrara M, Capozzi L, Coppola A, Save G, Coppola L. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.  Hematology 2007;12(4):297‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1080/10245330701255213', 'https://www.ncbi.nlm.nih.gov/pubmed/17654055', 'https://scholar.google.com/scholar_lookup?title=Prophylactic+platelet+transfusion+in+children+with+thrombocytopenic+disorders:+a+retrospective+review+&author=M+Ferrara&author=L+Capozzi&author=A+Coppola&author=G+Save&author=L+Coppola&publication_year=2007&hl=en']",17654055,https://doi.org/10.1080/10245330701255213, Ferrara 2007 {published data only}  ,excluded,CD012342-bbs2-0003, Wrong study design ‐ retrospective analysis 
CD012342-bib-0004,"Grossman L, Mangal A, Hislop TG, Buskard NA. ",Preliminary report on a randomized study of prophylactic (P) vs. therapeutic (T) platelet transfusions, Blood ,1980,80,    ,['citation-journal']," Grossman L, Mangal A, Hislop TG, Buskard NA. Preliminary report on a randomized study of prophylactic (P) vs. therapeutic (T) platelet transfusions.  Blood 1980;80:271. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Preliminary+report+on+a+randomized+study+of+prophylactic+(P)+vs.+therapeutic+(T)+platelet+transfusions+&author=L+Grossman&author=A+Mangal&author=TG+Hislop&author=NA+Buskard&publication_year=1980&hl=en']",,, Grossman 1980 {published and unpublished data}  ,excluded,CD012342-bbs2-0004, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0005,"Pisciotto PT, Benson K, Hume H, Glassman AB, Oberman H, Popovsky M, et al. ",Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients, Transfusion ,1995,35,    ,['citation-journal']," Pisciotto PT, Benson K, Hume H, Glassman AB, Oberman H, Popovsky M, et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients.  Transfusion 1995;35(6):498‐502. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1537-2995.1995.35695288769.x', 'https://www.ncbi.nlm.nih.gov/pubmed/7770901', 'https://scholar.google.com/scholar_lookup?title=Prophylactic+versus+therapeutic+platelet+transfusion+practices+in+hematology+and/or+oncology+patients+&author=PT+Pisciotto&author=K+Benson&author=H+Hume&author=AB+Glassman&author=H+Oberman&author=M+Popovsky&publication_year=1995&hl=en']",7770901,https://doi.org/10.1046/j.1537-2995.1995.35695288769.x, Pisciotto 1995 {published data only}  ,excluded,CD012342-bbs2-0005, Wrong study design ‐ survey of institutional members of blood bank 
CD012342-bib-0006,"Sagmeister M, Oec L, Gmur JA. ",A restrictive platelet transfusion policy allowing long term support of outpatients with severe aplastic anaemia, Blood ,1999,93,    ,['citation-journal']," Sagmeister M, Oec L, Gmur JA. A restrictive platelet transfusion policy allowing long term support of outpatients with severe aplastic anaemia.  Blood 1999;93:3124–6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V93.9.3124', 'https://www.ncbi.nlm.nih.gov/pubmed/10216111', 'https://scholar.google.com/scholar_lookup?title=A+restrictive+platelet+transfusion+policy+allowing+long+term+support+of+outpatients+with+severe+aplastic+anaemia+&author=M+Sagmeister&author=L+Oec&author=JA+Gmur&publication_year=1999&hl=en']",10216111,https://doi.org/10.1182/blood.V93.9.3124, Sagmeister 1999 {published data only}  ,excluded,CD012342-bbs2-0006, Wrong study design ‐ retrospective evaluation 
CD012342-bib-0007,"Siitonen T, Koistinen P. ",Prophylactic platelet transfusion in patients with hematologic diseases, Verensiirtoboito ,2004,120,    ,['citation-journal']," Siitonen T, Koistinen P. Prophylactic platelet transfusion in patients with hematologic diseases [Veritautipotilaiden profylaktiset trombosyyttien siirrot].  Verensiirtoboito 2004;120(7):877‐84. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Prophylactic+platelet+transfusion+in+patients+with+hematologic+diseases&author=T+Siitonen&author=P+Koistinen&publication_year=2004&hl=en']",,, Siitonen 2004 {published data only}  ,excluded,CD012342-bbs2-0007, Wrong study design ‐ survey 
CD012342-bib-0008,"Sintnicolaas K, van de Velden K, Sizoo W, Haije WG, Abels J, Lowenberg B. ",Comparison of 'prophylactic' and 'therapeutic' single‐donor platelet transfusions in patients with acute leukemia, British Journal of Haematology ,1981,50,    ,['citation-journal']," Sintnicolaas K, van de Velden K, Sizoo W, Haije WG, Abels J, Lowenberg B. Comparison of 'prophylactic' and 'therapeutic' single‐donor platelet transfusions in patients with acute leukemia.  British Journal of Haematology 1981;50(4):684. CENTRAL    Google Scholar     ","['', ""https://scholar.google.com/scholar_lookup?title=Comparison+of+'prophylactic'+and+'therapeutic'+single‐donor+platelet+transfusions+in+patients+with+acute+leukemia+&author=K+Sintnicolaas&author=K+Velden&author=W+Sizoo&author=WG+Haije&author=J+Abels&author=B+Lowenberg&publication_year=1981&hl=en""]",,, Sintnicolaas 1981 {published data only}  ,excluded,CD012342-bbs2-0008, Wrong patient population ‐ single‐donor platelets versus multiple‐donor platelets 
CD012342-bib-0009,ISRCTN08758735. ,A randomised controlled trial of prophylactic versus no‐prophylactic platelet transfusion in patient with haematological malignancies,,,,   ,['citation-other'], ISRCTN08758735. A randomised controlled trial of prophylactic versus no‐prophylactic platelet transfusion in patient with haematological malignancies. www.isrctn.com/ISRCTN08758735 (first received 31 July 2006). CENTRAL    ,[''],,, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0010,"Stanworth SJ, Dyer C, Choo L, Bakrania L, Copplestone A, Llewelyn C, et al. ","Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions?: Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions", Transfusion Medicine Reviews ,2010,24,    ,['citation-journal']," Stanworth SJ, Dyer C, Choo L, Bakrania L, Copplestone A, Llewelyn C, et al. Do all patients with hematologic malignancies and severe thrombocytopenia need prophylactic platelet transfusions?: Background, rationale, and design of a clinical trial (trial of platelet prophylaxis) to assess the effectiveness of prophylactic platelet transfusions.  Transfusion Medicine Reviews 2010;24(3):163‐71. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/20656185', 'https://scholar.google.com/scholar_lookup?title=Do+all+patients+with+hematologic+malignancies+and+severe+thrombocytopenia+need+prophylactic+platelet+transfusions?:+Background,+rationale,+and+design+of+a+clinical+trial+(trial+of+platelet+prophylaxis)+to+assess+the+effectiveness+of+prophylactic+platelet+transfusions+&author=SJ+Stanworth&author=C+Dyer&author=L+Choo&author=L+Bakrania&author=A+Copplestone&author=C+Llewelyn&publication_year=2010&hl=en']",20656185,, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0011,"Stanworth SJ, Estcourt L, Powter G, Kahan BC, Dyer C, Bakrania L, et al. ","The effect of a no‐prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe thrombocytopenia (TOPPS trial). A randomized controlled, non‐inferiority trial", Blood ,2012,120,    ,['citation-journal']," Stanworth SJ, Estcourt L, Powter G, Kahan BC, Dyer C, Bakrania L, et al. The effect of a no‐prophylactic versus prophylactic platelet transfusion strategy on bleeding in patients with hematological malignancies and severe thrombocytopenia (TOPPS trial). A randomized controlled, non‐inferiority trial.  Blood 2012;120(21):1. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V120.21.1.1', 'https://www.ncbi.nlm.nih.gov/pubmed/22767572', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+a+no‐prophylactic+versus+prophylactic+platelet+transfusion+strategy+on+bleeding+in+patients+with+hematological+malignancies+and+severe+thrombocytopenia+(TOPPS+trial).+A+randomized+controlled,+non‐inferiority+trial+&author=SJ+Stanworth&author=L+Estcourt&author=G+Powter&author=BC+Kahan&author=C+Dyer&author=L+Bakrania&publication_year=2012&hl=en']",22767572,https://doi.org/10.1182/blood.V120.21.1.1, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0012,"Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM. ",Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial (CME), Transfusion ,2014,54,    ,['citation-journal']," Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial (CME).  Transfusion 2014;54(10):2385‐93. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/trf.12646', 'https://www.ncbi.nlm.nih.gov/pubmed/24724863', 'https://scholar.google.com/scholar_lookup?title=Impact+of+prophylactic+platelet+transfusions+on+bleeding+events+in+patients+with+hematologic+malignancies:+a+subgroup+analysis+of+a+randomized+trial+(CME)+&author=SJ+Stanworth&author=LJ+Estcourt&author=CA+Llewelyn&author=MF+Murphy&author=EM+Wood&publication_year=2014&hl=en']",24724863,https://doi.org/10.1111/trf.12646, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0013,"Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, et al. ",A no‐prophylaxis platelet‐transfusion strategy for hematologic cancers, New England Journal of Medicine ,2013,368,    ,['citation-journal']," Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, et al. A no‐prophylaxis platelet‐transfusion strategy for hematologic cancers.  New England Journal of Medicine 2013;368(19):1771‐80. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa1212772', 'https://www.ncbi.nlm.nih.gov/pubmed/23656642', 'https://scholar.google.com/scholar_lookup?title=A+no‐prophylaxis+platelet‐transfusion+strategy+for+hematologic+cancers&author=SJ+Stanworth&author=LJ+Estcourt&author=G+Powter&author=BC+Kahan&author=C+Dyer&author=L+Choo&publication_year=2013&hl=en']",23656642,https://doi.org/10.1056/NEJMoa1212772, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0014,"Stanworth SJ, Hudson CL, Estcourt LJ, Johnson RJ, Wood EM, TOPPS study investigators. ",Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis, Haematologica ,2015,100,    ,['citation-journal']," Stanworth SJ, Hudson CL, Estcourt LJ, Johnson RJ, Wood EM, TOPPS study investigators. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.  Haematologica 2015;100(6):740‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3324/haematol.2014.118075', 'https://www.ncbi.nlm.nih.gov/pubmed/25795717', 'https://scholar.google.com/scholar_lookup?title=Risk+of+bleeding+and+use+of+platelet+transfusions+in+patients+with+hematologic+malignancies:+recurrent+event+analysis+&author=SJ+Stanworth&author=CL+Hudson&author=LJ+Estcourt&author=RJ+Johnson&author=EM+Wood&publication_year=2015&hl=en']",25795717,https://doi.org/10.3324/haematol.2014.118075, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0015,"Wood EM, Hudson C, Estcourt L, Johnson R, Stanworth SJ. ",Risk factors for bleeding: a modelling analysis of the TOPPS randomized controlled trial of prophylactic platelet transfusion, Blood ,2014,124,    ,['citation-journal']," Wood EM, Hudson C, Estcourt L, Johnson R, Stanworth SJ. Risk factors for bleeding: a modelling analysis of the TOPPS randomized controlled trial of prophylactic platelet transfusion.  Blood 2014;124:1551. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1182/blood.V124.21.1551.1551', 'https://www.ncbi.nlm.nih.gov/pubmed/25190753', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+bleeding:+a+modelling+analysis+of+the+TOPPS+randomized+controlled+trial+of+prophylactic+platelet+transfusion+&author=EM+Wood&author=C+Hudson&author=L+Estcourt&author=R+Johnson&author=SJ+Stanworth&publication_year=2014&hl=en']",25190753,https://doi.org/10.1182/blood.V124.21.1551.1551, Stanworth 2013 {published data only}  ,excluded,CD012342-bbs2-0009, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0016,NCT00521664. ,A trial comparing a prophylactic with a therapeutic platelet transfusion strategy in two groups,,,,   ,['citation-other'], NCT00521664. A trial comparing a prophylactic with a therapeutic platelet transfusion strategy in two groups. clinicaltrials.gov/ct2/show/NCT00521664 (first received 27 August 2007). CENTRAL    ,[''],,, Wandt 2012 {published data only}  ,excluded,CD012342-bbs2-0010, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0018,Wandt H. ,Indication for platelet transfusion in patients with haematological disease: less is more, Deutsche Medizinische Wochenschrift ,2010,135,    ,['citation-journal'], Wandt H. Indication for platelet transfusion in patients with haematological disease: less is more.  Deutsche Medizinische Wochenschrift 2010;135(38):1877–9. CENTRAL    PubMed     Google Scholar     ,"['', 'https://www.ncbi.nlm.nih.gov/pubmed/20842610', 'https://scholar.google.com/scholar_lookup?title=Indication+for+platelet+transfusion+in+patients+with+haematological+disease:+less+is+more+&author=H+Wandt&publication_year=2010&hl=en']",20842610,, Wandt 2012 {published data only}  ,excluded,CD012342-bbs2-0010, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0017,"Wandt H, Schaefer‐Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, et al. ","Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open‐label, multicentre, randomised study", Lancet ,2012,380,    ,['citation-journal']," Wandt H, Schaefer‐Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open‐label, multicentre, randomised study.  Lancet 2012;380(9850):1309–16. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(12)60689-8', 'https://www.ncbi.nlm.nih.gov/pubmed/22877506', 'https://scholar.google.com/scholar_lookup?title=Therapeutic+platelet+transfusion+versus+routine+prophylactic+transfusion+in+patients+with+haematological+malignancies:+an+open‐label,+multicentre,+randomised+study+&author=H+Wandt&author=K+Schaefer‐Eckart&author=K+Wendelin&author=B+Pilz&author=M+Wilhelm&author=M+Thalheimer&publication_year=2012&hl=en']",22877506,https://doi.org/10.1016/S0140-6736(12)60689-8, Wandt 2012 {published data only}  ,excluded,CD012342-bbs2-0010, Wrong patient population ‐ only people receiving intensive chemotherapy 
CD012342-bib-0019,Beutler E. ,"Platelet transfusions: the 20,000/μL trigger", Blood ,1993,81,    ,['citation-journal']," Beutler E. Platelet transfusions: the 20,000/μL trigger.  Blood 1993;81:1411‐3.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1182/blood.V81.6.1411.1411', 'https://www.ncbi.nlm.nih.gov/pubmed/8453089', 'https://scholar.google.com/scholar_lookup?title=Platelet+transfusions:+the+20,000/μL+trigger&author=E+Beutler&publication_year=1993&hl=en']",8453089,https://doi.org/10.1182/blood.V81.6.1411.1411, Beutler 1993 ,additional,CD012342-bbs2-0011,
CD012342-bib-0020,"Blumberg N, Heal JM, Phillips GL. ","Platelet transfusions: trigger, dose, benefits, and risks",,2010,,    ,['citation-other']," Blumberg N, Heal JM, Phillips GL. Platelet transfusions: trigger, dose, benefits, and risks. F1000 Medical Reports2010; Vol. 2:5.    Google Scholar     ","['https://scholar.google.com/scholar_lookup?title=Platelet+transfusions:+trigger,+dose,+benefits,+and+risks&author=N+Blumberg&author=JM+Heal&author=GL+Phillips&publication_year=2010&hl=en']",,, Blumberg 2010 ,additional,CD012342-bbs2-0012,
CD012342-bib-0021,"Bosly A, Muylle L, Noens L, Pietersz R, Heim D, Hübner R, et al. ",Guidelines for transfusion of platelets, Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine ,2007,62,    ,['citation-journal']," Bosly A, Muylle L, Noens L, Pietersz R, Heim D, Hübner R, et al. Guidelines for transfusion of platelets.  Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine 2007;62(1):36‐47.    Link to article     Google Scholar     ","['https://doi.org/10.1179/acb.2007.006', 'https://scholar.google.com/scholar_lookup?title=Guidelines+for+transfusion+of+platelets&author=A+Bosly&author=L+Muylle&author=L+Noens&author=R+Pietersz&author=D+Heim&author=R+Hübner&publication_year=2007&hl=en']",,https://doi.org/10.1179/acb.2007.006, Bosly 2007 ,additional,CD012342-bbs2-0013,
CD012342-bib-0022,"Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S. ",A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation, Cochrane Database of Systematic Reviews ,2015,,    ,['citation-journal']," Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S. A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.  Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD010981.pub2]    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/26422767', 'https://scholar.google.com/scholar_lookup?title=A+therapeutic‐only+versus+prophylactic+platelet+transfusion+strategy+for+preventing+bleeding+in+patients+with+haematological+disorders+after+myelosuppressive+chemotherapy+or+stem+cell+transplantation+&author=GL+Crighton&author=LJ+Estcourt&author=EM+Wood&author=M+Trivella&author=C+Doree&author=S+Stanworth&publication_year=2015&hl=en']",26422767,, Crighton 2015 ,additional,CD012342-bbs2-0014,
CD012342-bib-0023,"Deeks JJ, Higgins JP, Altman DG (editors). ","Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Deeks JJ, Higgins JP, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Deeks 2011 ,additional,CD012342-bbs2-0015,
CD012342-bib-0024,"Desborough M, Estcourt LJ, Chaimani A, Doree C, Hopewell S, Trivella M, et al. ",Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta‐analysis and systematic review, Cochrane Database of Systematic Reviews ,2016,,    ,['citation-journal']," Desborough M, Estcourt LJ, Chaimani A, Doree C, Hopewell S, Trivella M, et al. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta‐analysis and systematic review.  Cochrane Database of Systematic Reviews 2016, Issue 1. [DOI: 10.1002/14651858.CD012055]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD012055', 'https://scholar.google.com/scholar_lookup?title=Alternative+agents+versus+prophylactic+platelet+transfusion+for+preventing+bleeding+in+patients+with+thrombocytopenia+due+to+chronic+bone+marrow+failure:+a+network+meta‐analysis+and+systematic+review+&author=M+Desborough&author=LJ+Estcourt&author=A+Chaimani&author=C+Doree&author=S+Hopewell&author=M+Trivella&publication_year=2016&hl=en']",,https://doi.org/10.1002/14651858.CD012055, Desborough 2016 ,additional,CD012342-bbs2-0016,
CD012342-bib-0025,"Dinmohamed AG, Visser O, Van Norden Y, Huijgens PC, Sonneveld P, Van de Loosdrecht AA, et al. ","Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population‐based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010", European Journal of Cancer ,2014,50,    ,['citation-journal']," Dinmohamed AG, Visser O, Van Norden Y, Huijgens PC, Sonneveld P, Van de Loosdrecht AA, et al. Trends in incidence, initial treatment and survival of myelodysplastic syndromes: a population‐based study of 5144 patients diagnosed in the Netherlands from 2001 to 2010.  European Journal of Cancer 2014;50(5):1004‐12.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ejca.2013.12.002', 'https://www.ncbi.nlm.nih.gov/pubmed/24388662', 'https://scholar.google.com/scholar_lookup?title=Trends+in+incidence,+initial+treatment+and+survival+of+myelodysplastic+syndromes:+a+population‐based+study+of+5144+patients+diagnosed+in+the+Netherlands+from+2001+to+2010+&author=AG+Dinmohamed&author=O+Visser&author=Y+Norden&author=PC+Huijgens&author=P+Sonneveld&author=AA+Loosdrecht&publication_year=2014&hl=en']",24388662,https://doi.org/10.1016/j.ejca.2013.12.002, Dinmohamed 2014 ,additional,CD012342-bbs2-0017,
CD012342-bib-0026,"Effective Practice, Organisation of Care (EPOC). ",EPOC Resources for review authors,,,,. www.epoc.cochrane.org/epoc‐specific‐resources‐review‐authors (accessed prior to 4 July 2017).   ,['citation-other']," Effective Practice, Organisation of Care (EPOC). EPOC Resources for review authors. www.epoc.cochrane.org/epoc‐specific‐resources‐review‐authors (accessed prior to 4 July 2017).    ",[],,, EPOC 2015 ,additional,CD012342-bbs2-0018,
CD012342-bib-0027,"Estcourt LJ, Heddle N, Kaufman RM, McCullough J, Murphy MF, Slichter S, et al. On behalf of the BEST (Biomedical Excellence for Safer Transfusion) Collaborative. ",The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions, Transfusion ,2013,53,    ,['citation-journal']," Estcourt LJ, Heddle N, Kaufman RM, McCullough J, Murphy MF, Slichter S, et al. On behalf of the BEST (Biomedical Excellence for Safer Transfusion) Collaborative. The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.  Transfusion 2013;53(7):1531‐43.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/trf.12058', 'https://www.ncbi.nlm.nih.gov/pubmed/23305609', 'https://scholar.google.com/scholar_lookup?title=The+challenges+of+measuring+bleeding+outcomes+in+clinical+trials+of+platelet+transfusions&author=LJ+Estcourt&author=N+Heddle&author=RM+Kaufman&author=J+McCullough&author=MF+Murphy&author=S+Slichter&publication_year=2013&hl=en']",23305609,https://doi.org/10.1111/trf.12058, Estcourt 2013 ,additional,CD012342-bbs2-0019,
CD012342-bib-0028,"Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. ",Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation, Cochrane Database of Systematic Reviews ,2015,,    ,['citation-journal']," Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.  Cochrane Database of Systematic Reviews 2015, Issue 11. [DOI: 10.1002/14651858.CD010983.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD010983.pub2', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+different+platelet+count+thresholds+to+guide+administration+of+prophylactic+platelet+transfusion+for+preventing+bleeding+in+people+with+haematological+disorders+after+myelosuppressive+chemotherapy+or+stem+cell+transplantation+&author=LJ+Estcourt&author=SJ+Stanworth&author=C+Doree&author=S+Hopewell&author=M+Trivella&author=MF+Murphy&publication_year=2015&hl=en']",,https://doi.org/10.1002/14651858.CD010983.pub2, Estcourt 2015 ,additional,CD012342-bbs2-0020,
CD012342-bib-0029,"Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. ",Guidelines for the use of platelet transfusions, British Journal of Haematology ,2017,176,    ,['citation-journal']," Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, et al. Guidelines for the use of platelet transfusions.  British Journal of Haematology 2017;176:365–94.    Link to article     Google Scholar     ","['https://doi.org/10.1111/bjh.14423', 'https://scholar.google.com/scholar_lookup?title=Guidelines+for+the+use+of+platelet+transfusions&author=LJ+Estcourt&author=J+Birchall&author=S+Allard&author=SJ+Bassey&author=P+Hersey&author=JP+Kerr&publication_year=2017&hl=en']",,https://doi.org/10.1111/bjh.14423, Estcourt 2017 ,additional,CD012342-bbs2-0021,
CD012342-bib-0030,"Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S. ",Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?, Transfusion Medicine Reviews ,2002,16,    ,['citation-journal']," Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S. Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients?.  Transfusion Medicine Reviews 2002;16:34‐45.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1053/tmrv.2002.29403', 'https://www.ncbi.nlm.nih.gov/pubmed/11788928', 'https://scholar.google.com/scholar_lookup?title=Do+basic+laboratory+tests+or+clinical+observations+predict+bleeding+in+thrombocytopenic+oncology+patients?+&author=AM+Friedmann&author=H+Sengul&author=H+Lehmann&author=C+Schwartz&author=S+Goodman&publication_year=2002&hl=en']",11788928,https://doi.org/10.1053/tmrv.2002.29403, Friedmann 2002 ,additional,CD012342-bbs2-0022,
CD012342-bib-0031,"Fuller AK, Uglik KM, Braine HG, King KE. ",A comprehensive program to minimize platelet outdating, Transfusion ,2011,51,    ,['citation-journal']," Fuller AK, Uglik KM, Braine HG, King KE. A comprehensive program to minimize platelet outdating.  Transfusion 2011;51(7):1469‐76.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1537-2995.2010.03039.x', 'https://www.ncbi.nlm.nih.gov/pubmed/21303370', 'https://scholar.google.com/scholar_lookup?title=A+comprehensive+program+to+minimize+platelet+outdating&author=AK+Fuller&author=KM+Uglik&author=HG+Braine&author=KE+King&publication_year=2011&hl=en']",21303370,https://doi.org/10.1111/j.1537-2995.2010.03039.x, Fuller 2011 ,additional,CD012342-bbs2-0023,
CD012342-bib-0032,Garcia‐Manero G. ,"Myelodysplastic syndromes: 2012 update on diagnosis, risk‐stratification, and management", American Journal of Hematology ,2012,87,    ,['citation-journal']," Garcia‐Manero G. Myelodysplastic syndromes: 2012 update on diagnosis, risk‐stratification, and management.  American Journal of Hematology 2012;87(7):692‐701.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/ajh.23264', 'https://www.ncbi.nlm.nih.gov/pubmed/22696212', 'https://scholar.google.com/scholar_lookup?title=Myelodysplastic+syndromes:+2012+update+on+diagnosis,+risk‐stratification,+and+management&author=G+Garcia‐Manero&publication_year=2012&hl=en']",22696212,https://doi.org/10.1002/ajh.23264, Garcia‐Manero 2012 ,additional,CD012342-bbs2-0024,
CD012342-bib-0033,"Gaydos LA, Freireich EJ, Mantel N. ",The quantitative relation between platelet count and hemorrhage in patients with acute leukemia, New England Journal of Medicine ,1962,266,    ,['citation-journal']," Gaydos LA, Freireich EJ, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia.  New England Journal of Medicine 1962;266(18):905‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJM196205032661802', 'https://www.ncbi.nlm.nih.gov/pubmed/13897369', 'https://scholar.google.com/scholar_lookup?title=The+quantitative+relation+between+platelet+count+and+hemorrhage+in+patients+with+acute+leukemia+&author=LA+Gaydos&author=EJ+Freireich&author=N+Mantel&publication_year=1962&hl=en']",13897369,https://doi.org/10.1056/NEJM196205032661802, Gaydos 1962 ,additional,CD012342-bbs2-0025,
CD012342-bib-0034,Executive Committee of the German Medical Association on the recommendation of the Scientific Advisory Board. ,Cross‐sectional guidelines for therapy with blood components and plasma derivatives,,,,. www.bundesaerztekammer.de/aerzte/medizin‐ethik/wissenschaftlicher‐beirat/veroeffentlichungen/haemotherapie‐transfusionsmedizin/english/ 2014 (accessed prior to 21 January 2016).   ,['citation-other'], Executive Committee of the German Medical Association on the recommendation of the Scientific Advisory Board. Cross‐sectional guidelines for therapy with blood components and plasma derivatives. www.bundesaerztekammer.de/aerzte/medizin‐ethik/wissenschaftlicher‐beirat/veroeffentlichungen/haemotherapie‐transfusionsmedizin/english/ 2014 (accessed prior to 21 January 2016).    ,[],,, German Medical Association 2014 ,additional,CD012342-bbs2-0026,
CD012342-bib-0035,Giri N. ,The inherited bone marrow failure syndromes, Haematologia ,2004,8,    ,['citation-journal'], Giri N. The inherited bone marrow failure syndromes.  Haematologia 2004;8(2):57‐9.    Google Scholar     ,['https://scholar.google.com/scholar_lookup?title=The+inherited+bone+marrow+failure+syndromes&author=N+Giri&publication_year=2004&hl=en'],,, Giri 2004 ,additional,CD012342-bbs2-0027,
CD012342-bib-0036,"Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. ",Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia, Lancet ,1991,338,    ,['citation-journal']," Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia.  Lancet 1991;338(8777):1223‐6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/0140-6736(91)92098-M', 'https://www.ncbi.nlm.nih.gov/pubmed/1682642', 'https://scholar.google.com/scholar_lookup?title=Safety+of+stringent+prophylactic+platelet+transfusion+policy+for+patients+with+acute+leukaemia+&author=J+Gmur&author=J+Burger&author=U+Schanz&author=J+Fehr&author=A+Schaffner&publication_year=1991&hl=en']",1682642,https://doi.org/10.1016/0140-6736(91)92098-M, Gmur 1991 ,additional,CD012342-bbs2-0028,
CD012342-bib-0037,"Hellström‐Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, et al. ",A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin and granulocyte colony‐stimulating factor: significant effects on quality of life, British Journal of Haematology ,2003,120,    ,['citation-journal']," Hellström‐Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, et al. A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin and granulocyte colony‐stimulating factor: significant effects on quality of life.  British Journal of Haematology 2003;120(6):1037‐46.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1046/j.1365-2141.2003.04153.x', 'https://www.ncbi.nlm.nih.gov/pubmed/12648074', 'https://scholar.google.com/scholar_lookup?title=A+validated+decision+model+for+treating+the+anaemia+of+myelodysplastic+syndromes+with+erythropoietin+and+granulocyte+colony‐stimulating+factor:+significant+effects+on+quality+of+life+&author=E+Hellström‐Lindberg&author=N+Gulbrandsen&author=G+Lindberg&author=T+Ahlgren&author=IM+Dahl&author=I+Dybedal&publication_year=2003&hl=en']",12648074,https://doi.org/10.1046/j.1365-2141.2003.04153.x, Hellstrom‐Lindberg 2003 ,additional,CD012342-bbs2-0029,
CD012342-bib-0038,"Higgins JP, Deeks JJ (editors). ","Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Higgins JP, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Higgins 2011a ,additional,CD012342-bbs2-0030,
CD012342-bib-0039,"Higgins JP, Altman DG, Sterne JA (editors). ","Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Higgins JP, Altman DG, Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Higgins 2011b ,additional,CD012342-bbs2-0031,
CD012342-bib-0040,"Higgins JP, Deeks JJ, Altman DG (editors). ","Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Higgins JP, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Higgins 2011c ,additional,CD012342-bbs2-0032,
CD012342-bib-0041,"Higgins JP, Deeks JJ, Altman DG on behalf of the Cochrane Statistical Methods Group (editors). ","Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Higgins JP, Deeks JJ, Altman DG on behalf of the Cochrane Statistical Methods Group (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Higgins 2011d ,additional,CD012342-bbs2-0033,
CD012342-bib-0042,"Hod E, Schwartz J. ",Platelet transfusion refractoriness, British Journal of Haematology ,2008,42,    ,['citation-journal']," Hod E, Schwartz J. Platelet transfusion refractoriness.  British Journal of Haematology 2008;42(3):348‐60.    Link to article     Google Scholar     ","['https://doi.org/10.1111/j.1365-2141.2008.07189.x', 'https://scholar.google.com/scholar_lookup?title=Platelet+transfusion+refractoriness&author=E+Hod&author=J+Schwartz&publication_year=2008&hl=en']",,https://doi.org/10.1111/j.1365-2141.2008.07189.x, Hod 2008 ,additional,CD012342-bbs2-0034,
CD012342-bib-0043,"Issaragrisil S, Kaufman D, Anderson T, Chansung K, Leaverton P, Shapiro S, et al. ",The epidemiology of aplastic anemia in Thailand, Blood ,2006,107,    ,['citation-journal']," Issaragrisil S, Kaufman D, Anderson T, Chansung K, Leaverton P, Shapiro S, et al. The epidemiology of aplastic anemia in Thailand.  Blood 2006;107:1299–307.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1182/blood-2005-01-0161', 'https://www.ncbi.nlm.nih.gov/pubmed/16254144', 'https://scholar.google.com/scholar_lookup?title=The+epidemiology+of+aplastic+anemia+in+Thailand&author=S+Issaragrisil&author=D+Kaufman&author=T+Anderson&author=K+Chansung&author=P+Leaverton&author=S+Shapiro&publication_year=2006&hl=en']",16254144,https://doi.org/10.1182/blood-2005-01-0161, Issaragrisil 2006 ,additional,CD012342-bbs2-0035,
CD012342-bib-0044,"Kantarjian H, Giles F, List A, Lyons R, Sekeres MA, Pierce S, et al. ",The incidence and impact of thrombocytopenia in myelodysplastic syndromes, Cancer ,2007,109,    ,['citation-journal']," Kantarjian H, Giles F, List A, Lyons R, Sekeres MA, Pierce S, et al. The incidence and impact of thrombocytopenia in myelodysplastic syndromes.  Cancer 2007;109:1705–14.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/cncr.22602', 'https://www.ncbi.nlm.nih.gov/pubmed/17366593', 'https://scholar.google.com/scholar_lookup?title=The+incidence+and+impact+of+thrombocytopenia+in+myelodysplastic+syndromes&author=H+Kantarjian&author=F+Giles&author=A+List&author=R+Lyons&author=MA+Sekeres&author=S+Pierce&publication_year=2007&hl=en']",17366593,https://doi.org/10.1002/cncr.22602, Kantarjian 2007 ,additional,CD012342-bbs2-0036,
CD012342-bib-0045,"Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. ",Platelet transfusion: a clinical practice guideline from the AABB, Annals of Internal Medicine ,2015,162,    ,['citation-journal']," Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, et al. Platelet transfusion: a clinical practice guideline from the AABB.  Annals of Internal Medicine 2015;162:205‐13.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/M14-1589', 'https://www.ncbi.nlm.nih.gov/pubmed/25383671', 'https://scholar.google.com/scholar_lookup?title=Platelet+transfusion:+a+clinical+practice+guideline+from+the+AABB&author=RM+Kaufman&author=B+Djulbegovic&author=T+Gernsheimer&author=S+Kleinman&author=AT+Tinmouth&author=KE+Capocelli&publication_year=2015&hl=en']",25383671,https://doi.org/10.7326/M14-1589, Kaufman 2015 ,additional,CD012342-bbs2-0037,
CD012342-bib-0046,"Killick SB, Carter C, Culligan D, Dalley C, Das‐Gupta E, Drummond M, et al. ",Guidelines for the diagnosis and management of adult myelodysplastic syndromes, British Journal of Haematology ,2014,164,    ,['citation-journal']," Killick SB, Carter C, Culligan D, Dalley C, Das‐Gupta E, Drummond M, et al. Guidelines for the diagnosis and management of adult myelodysplastic syndromes.  British Journal of Haematology 2014;164(4):503‐25.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/bjh.12694', 'https://www.ncbi.nlm.nih.gov/pubmed/24372298', 'https://scholar.google.com/scholar_lookup?title=Guidelines+for+the+diagnosis+and+management+of+adult+myelodysplastic+syndromes&author=SB+Killick&author=C+Carter&author=D+Culligan&author=C+Dalley&author=E+Das‐Gupta&author=M+Drummond&publication_year=2014&hl=en']",24372298,https://doi.org/10.1111/bjh.12694, Killick 2014 ,additional,CD012342-bbs2-0038,
CD012342-bib-0047,"Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. ",Guidelines for the diagnosis and management of adult aplastic anaemia, British Journal of Haematology ,2016,172,    ,['citation-journal']," Killick SB, Bown N, Cavenagh J, Dokal I, Foukaneli T, Hill A, et al. Guidelines for the diagnosis and management of adult aplastic anaemia.  British Journal of Haematology 2016;172(2):187‐207.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/bjh.13853', 'https://www.ncbi.nlm.nih.gov/pubmed/26568159', 'https://scholar.google.com/scholar_lookup?title=Guidelines+for+the+diagnosis+and+management+of+adult+aplastic+anaemia&author=SB+Killick&author=N+Bown&author=J+Cavenagh&author=I+Dokal&author=T+Foukaneli&author=A+Hill&publication_year=2016&hl=en']",26568159,https://doi.org/10.1111/bjh.13853, Killick 2016 ,additional,CD012342-bbs2-0039,
CD012342-bib-0048,"Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, et al. ","Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony‐stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer", Journal of Clinical Oncology ,2007,25,    ,['citation-journal']," Le Deley MC, Suzan F, Cutuli B, Delaloge S, Shamsaldin A, Linassier C, et al. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony‐stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.  Journal of Clinical Oncology 2007;25(3):292‐300.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2006.05.9048', 'https://www.ncbi.nlm.nih.gov/pubmed/17159192', 'https://scholar.google.com/scholar_lookup?title=Anthracyclines,+mitoxantrone,+radiotherapy,+and+granulocyte+colony‐stimulating+factor:+risk+factors+for+leukemia+and+myelodysplastic+syndrome+after+breast+cancer+&author=MC+Deley&author=F+Suzan&author=B+Cutuli&author=S+Delaloge&author=A+Shamsaldin&author=C+Linassier&publication_year=2007&hl=en']",17159192,https://doi.org/10.1200/JCO.2006.05.9048, Le Deley 2007 ,additional,CD012342-bbs2-0040,
CD012342-bib-0049,"Lee TH, Wong JG, Leo YS, Thein TL, Ng EL, Lee LK, et al. ",Potential harm of prophylactic platelet transfusion in adult dengue patients, PLoS Neglected Tropical Diseases ,2016,10,    ,['citation-journal']," Lee TH, Wong JG, Leo YS, Thein TL, Ng EL, Lee LK, et al. Potential harm of prophylactic platelet transfusion in adult dengue patients.  PLoS Neglected Tropical Diseases 2016;10(3):e0004576.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pntd.0004576', 'https://www.ncbi.nlm.nih.gov/pubmed/27015272', 'https://scholar.google.com/scholar_lookup?title=Potential+harm+of+prophylactic+platelet+transfusion+in+adult+dengue+patients&author=TH+Lee&author=JG+Wong&author=YS+Leo&author=TL+Thein&author=EL+Ng&author=LK+Lee&publication_year=2016&hl=en']",27015272,https://doi.org/10.1371/journal.pntd.0004576, Lee 2016 ,additional,CD012342-bbs2-0041,
CD012342-bib-0050,"Lefebvre C, Manheimer E, Glanville J. ","Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Lefebvre 2011 ,additional,CD012342-bbs2-0042,
CD012342-bib-0051,"Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. ",Recommendations for the transfusion of plasma and platelets, Blood Transfusion ,2009,7,    ,['citation-journal']," Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G. Recommendations for the transfusion of plasma and platelets.  Blood Transfusion 2009;7(2):132‐50.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/19503635', 'https://scholar.google.com/scholar_lookup?title=Recommendations+for+the+transfusion+of+plasma+and+platelets&author=G+Liumbruno&author=F+Bennardello&author=A+Lattanzio&author=P+Piccoli&author=G+Rossetti&publication_year=2009&hl=en']",19503635,, Liumbruno 2009 ,additional,CD012342-bbs2-0043,
CD012342-bib-0052,"Ma X, Does M, Raza A, Mayne ST. ",Myelodysplastic syndromes: incidence and survival in the United States, Cancer ,2007,109,    ,['citation-journal']," Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States.  Cancer 2007;109(8):1536‐42.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/cncr.22570', 'https://www.ncbi.nlm.nih.gov/pubmed/17345612', 'https://scholar.google.com/scholar_lookup?title=Myelodysplastic+syndromes:+incidence+and+survival+in+the+United+States&author=X+Ma&author=M+Does&author=A+Raza&author=ST+Mayne&publication_year=2007&hl=en']",17345612,https://doi.org/10.1002/cncr.22570, Ma 2007 ,additional,CD012342-bbs2-0044,
CD012342-bib-0053,Ma X. ,Epidemiology of myelodysplastic syndromes, American Journal of Medicine ,2012,125,    ,['citation-journal'], Ma X. Epidemiology of myelodysplastic syndromes.  American Journal of Medicine 2012;125(7):S2‐5.    Link to article     PubMed     Google Scholar     ,"['https://doi.org/10.1016/j.amjmed.2012.04.014', 'https://www.ncbi.nlm.nih.gov/pubmed/22735748', 'https://scholar.google.com/scholar_lookup?title=Epidemiology+of+myelodysplastic+syndromes&author=X+Ma&publication_year=2012&hl=en']",22735748,https://doi.org/10.1016/j.amjmed.2012.04.014, Ma 2012 ,additional,CD012342-bbs2-0045,
CD012342-bib-0054,"McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. ",Health‐related quality of life measured using the EQ‐5D–5L: South Australian population norms, Health and Quality of Life Outcomes ,2016,14,    ,['citation-journal']," McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health‐related quality of life measured using the EQ‐5D–5L: South Australian population norms.  Health and Quality of Life Outcomes 2016;14:133.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/s12955-016-0537-0', 'https://www.ncbi.nlm.nih.gov/pubmed/27644755', 'https://scholar.google.com/scholar_lookup?title=Health‐related+quality+of+life+measured+using+the+EQ‐5D–5L:+South+Australian+population+norms+&author=N+McCaffrey&author=B+Kaambwa&author=DC+Currow&author=J+Ratcliffe&publication_year=2016&hl=en']",27644755,https://doi.org/10.1186/s12955-016-0537-0, McCaffrey 2016 ,additional,CD012342-bbs2-0046,
CD012342-bib-0055,"Moher D, Liberati A, Tetzlaff J, Altman DG. ",Preferred Reporting Items for Systematic reviews and Meta‐Analyses: The PRISMA Statement, Annals of Internal Medicine ,2009,151,    ,['citation-journal']," Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic reviews and Meta‐Analyses: The PRISMA Statement.  Annals of Internal Medicine 2009;151(4):264‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-151-4-200908180-00135', 'https://www.ncbi.nlm.nih.gov/pubmed/19622511', 'https://scholar.google.com/scholar_lookup?title=Preferred+Reporting+Items+for+Systematic+reviews+and+Meta‐Analyses:+The+PRISMA+Statement&author=D+Moher&author=A+Liberati&author=J+Tetzlaff&author=DG+Altman&publication_year=2009&hl=en']",19622511,https://doi.org/10.7326/0003-4819-151-4-200908180-00135, Moher 2009 ,additional,CD012342-bbs2-0047,
CD012342-bib-0056,"Montané E, Ibánëz, L, Vidal X, Ballarin E, Pig R, Garcia N, et al. ",Epidemiology of aplastic anemia: a prospective multicenter study, Haematologica ,2008,93,    ,['citation-journal']," Montané E, Ibánëz, L, Vidal X, Ballarin E, Pig R, Garcia N, et al. Epidemiology of aplastic anemia: a prospective multicenter study.  Haematologica 2008;93(4):518‐23.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3324/haematol.12020', 'https://www.ncbi.nlm.nih.gov/pubmed/18322256', 'https://scholar.google.com/scholar_lookup?title=Epidemiology+of+aplastic+anemia:+a+prospective+multicenter+study&author=E+Montané&author=+Ibánëz&author=+L&author=X+Vidal&author=E+Ballarin&author=R+Pig&author=N+Garcia&publication_year=2008&hl=en']",18322256,https://doi.org/10.3324/haematol.12020, Montané 2008 ,additional,CD012342-bbs2-0048,
CD012342-bib-0057,National Blood Authority. ,Patient Blood Management Guideline: Module 3 ‐ Medical,,,,. www.blood.gov.au/pbm‐module‐3 (accessed prior to 4 November 2017).   ,['citation-other'], National Blood Authority. Patient Blood Management Guideline: Module 3 ‐ Medical. www.blood.gov.au/pbm‐module‐3 (accessed prior to 4 November 2017).    ,[],,, NBA 2012 ,additional,CD012342-bbs2-0049,
CD012342-bib-0058,National Comparative Audit of Blood Transfusion (NCABT). ,Red cell & platelet transfusions in adult haematology patients,,,,. hospital.blood.co.uk/audits/national‐comparative‐audit/medical‐audits/2016‐red‐cell‐platelet‐transfusion‐in‐adult‐haematology‐patients/ (accessed prior to 10 October 2017).   ,['citation-other'], National Comparative Audit of Blood Transfusion (NCABT). Red cell & platelet transfusions in adult haematology patients. hospital.blood.co.uk/audits/national‐comparative‐audit/medical‐audits/2016‐red‐cell‐platelet‐transfusion‐in‐adult‐haematology‐patients/ (accessed prior to 10 October 2017).    ,[],,, NCABT 2016 ,additional,CD012342-bbs2-0050,
CD012342-bib-0059,"Neukirchen J, Schoonen WM, Strupp C, Gattermann N, Aul C, Haas R, et al. ",Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS‐registry, Leukemia Research ,2011,35,    ,['citation-journal']," Neukirchen J, Schoonen WM, Strupp C, Gattermann N, Aul C, Haas R, et al. Incidence and prevalence of myelodysplastic syndromes: data from the Dusseldorf MDS‐registry.  Leukemia Research 2011;35(12):1591‐6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.leukres.2011.06.001', 'https://www.ncbi.nlm.nih.gov/pubmed/21708407', 'https://scholar.google.com/scholar_lookup?title=Incidence+and+prevalence+of+myelodysplastic+syndromes:+data+from+the+Dusseldorf+MDS‐registry&author=J+Neukirchen&author=WM+Schoonen&author=C+Strupp&author=N+Gattermann&author=C+Aul&author=R+Haas&publication_year=2011&hl=en']",21708407,https://doi.org/10.1016/j.leukres.2011.06.001, Neukirchen 2011 ,additional,CD012342-bbs2-0051,
CD012342-bib-0060,National Institute for Health and Care Excellence. ,Blood transfusion NG24,,,,. www.nice.org.uk/guidance/ng24 2015 (accessed prior to 1 March 2016).   ,['citation-other'], National Institute for Health and Care Excellence. Blood transfusion NG24. www.nice.org.uk/guidance/ng24 2015 (accessed prior to 1 March 2016).    ,[],,, NICE 2015 ,additional,CD012342-bbs2-0052,
CD012342-bib-0061,"Parmar MK, Torri V, Stewart L. ",Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints, Statistics in Medicine ,1998,17,    ,['citation-journal']," Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints.  Statistics in Medicine 1998;17(24):2815‐34.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8', 'https://www.ncbi.nlm.nih.gov/pubmed/9921604', 'https://scholar.google.com/scholar_lookup?title=Extracting+summary+statistics+to+perform+meta‐analyses+of+the+published+literature+for+survival+endpoints+&author=MK+Parmar&author=V+Torri&author=L+Stewart&publication_year=1998&hl=en']",9921604,https://doi.org/10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8, Parmar 1998 ,additional,CD012342-bbs2-0053,
CD012342-bib-0062,"Rauff B, Idrees M, Shah SA, Butt S, Butt AM, Ali L, et al. ",Hepatitis associated aplastic anemia: a review, Virology Journal ,2011,28,    ,['citation-journal']," Rauff B, Idrees M, Shah SA, Butt S, Butt AM, Ali L, et al. Hepatitis associated aplastic anemia: a review.  Virology Journal 2011;28:87.    Link to article     Google Scholar     ","['https://doi.org/10.1186/1743-422X-8-87', 'https://scholar.google.com/scholar_lookup?title=Hepatitis+associated+aplastic+anemia:+a+review&author=B+Rauff&author=M+Idrees&author=SA+Shah&author=S+Butt&author=AM+Butt&author=L+Ali&publication_year=2011&hl=en']",,https://doi.org/10.1186/1743-422X-8-87, Rauff 2011 ,additional,CD012342-bbs2-0054,
CD012342-bib-0063,"Raval JS, Mazepa MA, Russell SL, Immel CC, Whinna HC, Park YA. ",Passive reporting greatly underestimates the rate of transfusion‐associated circulatory overload after platelet transfusion, Vox Sanguinis ,2015,108,    ,['citation-journal']," Raval JS, Mazepa MA, Russell SL, Immel CC, Whinna HC, Park YA. Passive reporting greatly underestimates the rate of transfusion‐associated circulatory overload after platelet transfusion.  Vox Sanguinis 2015;108(4):387‐92.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/vox.12234', 'https://www.ncbi.nlm.nih.gov/pubmed/25753261', 'https://scholar.google.com/scholar_lookup?title=Passive+reporting+greatly+underestimates+the+rate+of+transfusion‐associated+circulatory+overload+after+platelet+transfusion+&author=JS+Raval&author=MA+Mazepa&author=SL+Russell&author=CC+Immel&author=HC+Whinna&author=YA+Park&publication_year=2015&hl=en']",25753261,https://doi.org/10.1111/vox.12234, Raval 2015 ,additional,CD012342-bbs2-0055,
CD012342-bib-0064,"Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, et al. ",The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia, New England Journal of Medicine ,1997,337,    ,['citation-journal']," Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia.  New England Journal of Medicine 1997;337(26):1870‐5.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJM199712253372602', 'https://www.ncbi.nlm.nih.gov/pubmed/9407153', 'https://scholar.google.com/scholar_lookup?title=The+threshold+for+prophylactic+platelet+transfusions+in+adults+with+acute+myeloid+leukemia+&author=P+Rebulla&author=G+Finazzi&author=F+Marangoni&author=G+Avvisati&author=L+Gugliotta&author=G+Tognoni&publication_year=1997&hl=en']",9407153,https://doi.org/10.1056/NEJM199712253372602, Rebulla 1997 ,additional,CD012342-bbs2-0056,
CD012342-bib-0065,"Reeves BC, Deeks JJ, Higgins JP, Wells GA. ","Chapter 13: Including non‐randomised studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Reeves BC, Deeks JJ, Higgins JP, Wells GA. Chapter 13: Including non‐randomised studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Reeves 2011 ,additional,CD012342-bbs2-0057,
CD012342-bib-0066,The Nordic Cochrane Centre. The Cochrane Collaboration. ,Review Manager (RevMan),,2014,,.   ,['citation-other']," The Nordic Cochrane Centre. The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre. The Cochrane Collaboration, 2014.    ",[],,, RevMan 2014 [Computer program] ,additional,CD012342-bbs2-0058,
CD012342-bib-0067,"Riley W, Smalley B, Pulkrabek S, Clay ME, McCullough J. ",Using lean techniques to define the platelet (PLT) transfusion process and cost‐effectiveness to evaluate PLT dose transfusion strategies, Transfusion ,2012,52,    ,['citation-journal']," Riley W, Smalley B, Pulkrabek S, Clay ME, McCullough J. Using lean techniques to define the platelet (PLT) transfusion process and cost‐effectiveness to evaluate PLT dose transfusion strategies.  Transfusion 2012;52(9):1957‐67. [PUBMED: 22320153]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1537-2995.2011.03539.x', 'https://www.ncbi.nlm.nih.gov/pubmed/22320153', 'https://scholar.google.com/scholar_lookup?title=Using+lean+techniques+to+define+the+platelet+(PLT)+transfusion+process+and+cost‐effectiveness+to+evaluate+PLT+dose+transfusion+strategies+&author=W+Riley&author=B+Smalley&author=S+Pulkrabek&author=ME+Clay&author=J+McCullough&publication_year=2012&hl=en']",22320153,https://doi.org/10.1111/j.1537-2995.2011.03539.x, Riley 2012 ,additional,CD012342-bbs2-0059,
CD012342-bib-0068,"Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, et al. ","Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001‐2004, using data from the NAACCR and SEER programs", Blood ,2008,112,    ,['citation-journal']," Rollison DE, Howlader N, Smith MT, Strom SS, Merritt WD, Ries LA, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001‐2004, using data from the NAACCR and SEER programs.  Blood 2008;112(1):42‐52.    Link to article     Google Scholar     ","['https://doi.org/10.1182/blood-2008-01-134858', 'https://scholar.google.com/scholar_lookup?title=Epidemiology+of+myelodysplastic+syndromes+and+chronic+myeloproliferative+disorders+in+the+United+States,+2001‐2004,+using+data+from+the+NAACCR+and+SEER+programs+&author=DE+Rollison&author=N+Howlader&author=MT+Smith&author=SS+Strom&author=WD+Merritt&author=LA+Ries&publication_year=2008&hl=en']",,https://doi.org/10.1182/blood-2008-01-134858, Rollison 2008 ,additional,CD012342-bbs2-0060,
CD012342-bib-0069,"Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, et al. ",Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology, Journal of Clinical Oncology ,2001,19,    ,['citation-journal']," Schiffer CA, Anderson KC, Bennett CL, Bernstein S, Elting LS, Goldsmith M, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.  Journal of Clinical Oncology 2001;19(5):1519‐38.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2001.19.5.1519', 'https://www.ncbi.nlm.nih.gov/pubmed/11230498', 'https://scholar.google.com/scholar_lookup?title=Platelet+transfusion+for+patients+with+cancer:+clinical+practice+guidelines+of+the+American+Society+of+Clinical+Oncology+&author=CA+Schiffer&author=KC+Anderson&author=CL+Bennett&author=S+Bernstein&author=LS+Elting&author=M+Goldsmith&publication_year=2001&hl=en']",11230498,https://doi.org/10.1200/JCO.2001.19.5.1519, Schiffer 2001 ,additional,CD012342-bbs2-0061,
CD012342-bib-0070,Schiffer CA. ,Haematological cancer: Prophylactic platelet transfusion is frequently not necessary, Nature Review Clinical Oncology ,2013,10,    ,['citation-journal'], Schiffer CA. Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.  Nature Review Clinical Oncology 2013;10(8):431‐2.    Link to article     Google Scholar     ,"['https://doi.org/10.1038/nrclinonc.2013.113', 'https://scholar.google.com/scholar_lookup?title=Haematological+cancer:+Prophylactic+platelet+transfusion+is+frequently+not+necessary&author=CA+Schiffer&publication_year=2013&hl=en']",,https://doi.org/10.1038/nrclinonc.2013.113, Schiffer 2013 ,additional,CD012342-bbs2-0062,
CD012342-bib-0071,"Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, et al. ",Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update, Journal of Clinical Oncology ,2017,36,    ,['citation-journal']," Schiffer CA, Bohlke K, Delaney M, Hume H, Magdalinski AJ, McCullough JJ, et al. Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update.  Journal of Clinical Oncology 2017;36(3):283‐99.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1200/JCO.2017.76.1734', 'https://www.ncbi.nlm.nih.gov/pubmed/29182495', 'https://scholar.google.com/scholar_lookup?title=Platelet+transfusion+for+patients+with+cancer:+American+Society+of+Clinical+Oncology+clinical+practice+guideline+update+&author=CA+Schiffer&author=K+Bohlke&author=M+Delaney&author=H+Hume&author=AJ+Magdalinski&author=JJ+McCullough&publication_year=2017&hl=en']",29182495,https://doi.org/10.1200/JCO.2017.76.1734, Schiffer 2017 ,additional,CD012342-bbs2-0063,
CD012342-bib-0072,"Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. ","Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Schunemann 2011a ,additional,CD012342-bbs2-0064,
CD012342-bib-0073,"Schünemann HJ, Oxman AD, Vist GE, Higgins JP, Deeks JJ, Glasziou P, et al. ","Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Schünemann HJ, Oxman AD, Vist GE, Higgins JP, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Schunemann 2011b ,additional,CD012342-bbs2-0065,
CD012342-bib-0074,Sekeres MA. ,The epidemiology of myelodysplastic syndromes, Hematology/Oncology Clinics of North America ,2010,24,    ,['citation-journal'], Sekeres MA. The epidemiology of myelodysplastic syndromes.  Hematology/Oncology Clinics of North America 2010;24(2):287‐94.    Link to article     Google Scholar     ,"['https://doi.org/10.1016/j.hoc.2010.02.011', 'https://scholar.google.com/scholar_lookup?title=The+epidemiology+of+myelodysplastic+syndromes&author=MA+Sekeres&publication_year=2010&hl=en']",,https://doi.org/10.1016/j.hoc.2010.02.011, Sekeres 2010 ,additional,CD012342-bbs2-0066,
CD012342-bib-0075,Shimamura A. ,Clinical approach to marrow failure, ASH Education Program Book ,2009,2009,    ,['citation-journal'], Shimamura A. Clinical approach to marrow failure.  ASH Education Program Book 2009;2009(1):329‐37.    Link to article     Google Scholar     ,"['https://doi.org/10.1182/asheducation-2009.1.329', 'https://scholar.google.com/scholar_lookup?title=Clinical+approach+to+marrow+failure&author=A+Shimamura&publication_year=2009&hl=en']",,https://doi.org/10.1182/asheducation-2009.1.329, Shimamura 2009 ,additional,CD012342-bbs2-0067,
CD012342-bib-0076,"Slichter SJ, Harker LA. ",Thrombocytopenia: mechanisms and management of defects in platelet production, Clinics in Haematology ,1978,7,    ,['citation-journal']," Slichter SJ, Harker LA. Thrombocytopenia: mechanisms and management of defects in platelet production.  Clinics in Haematology 1978;7(3):523‐39.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0308-2261(21)00047-3', 'https://www.ncbi.nlm.nih.gov/pubmed/363326', 'https://scholar.google.com/scholar_lookup?title=Thrombocytopenia:+mechanisms+and+management+of+defects+in+platelet+production&author=SJ+Slichter&author=LA+Harker&publication_year=1978&hl=en']",363326,https://doi.org/10.1016/S0308-2261(21)00047-3, Slichter 1978 ,additional,CD012342-bbs2-0068,
CD012342-bib-0077,Slichter SJ. ,Relationship between platelet count and bleeding risk in thrombocytopenic patients, Transfusion Medicine Reviews ,2004,18,    ,['citation-journal'], Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients.  Transfusion Medicine Reviews 2004;18(3):153‐67.    Link to article     PubMed     Google Scholar     ,"['https://doi.org/10.1016/j.tmrv.2004.03.003', 'https://www.ncbi.nlm.nih.gov/pubmed/15248165', 'https://scholar.google.com/scholar_lookup?title=Relationship+between+platelet+count+and+bleeding+risk+in+thrombocytopenic+patients&author=SJ+Slichter&publication_year=2004&hl=en']",15248165,https://doi.org/10.1016/j.tmrv.2004.03.003, Slichter 2004 ,additional,CD012342-bbs2-0069,
CD012342-bib-0078,"Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, et al. ","Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients", Blood ,2005,105,    ,['citation-journal']," Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients.  Blood 2005;105(10):4106‐14.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1182/blood-2003-08-2724', 'https://www.ncbi.nlm.nih.gov/pubmed/15692069', 'https://scholar.google.com/scholar_lookup?title=Factors+affecting+posttransfusion+platelet+increments,+platelet+refractoriness,+and+platelet+transfusion+intervals+in+thrombocytopenic+patients+&author=SJ+Slichter&author=K+Davis&author=H+Enright&author=H+Braine&author=T+Gernsheimer&author=KJ+Kao&publication_year=2005&hl=en']",15692069,https://doi.org/10.1182/blood-2003-08-2724, Slichter 2005 ,additional,CD012342-bbs2-0070,
CD012342-bib-0079,"Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, et al. ",Dose of prophylactic platelet transfusions and prevention of hemorrhage, New England Journal of Medicine ,2010,362,    ,['citation-journal']," Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage.  New England Journal of Medicine 2010;362:600‐13.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJMoa0904084', 'https://www.ncbi.nlm.nih.gov/pubmed/20164484', 'https://scholar.google.com/scholar_lookup?title=Dose+of+prophylactic+platelet+transfusions+and+prevention+of+hemorrhage&author=SJ+Slichter&author=RM+Kaufman&author=SF+Assmann&author=J+McCullough&author=DJ+Triulzi&author=RG+Strauss&publication_year=2010&hl=en']",20164484,https://doi.org/10.1056/NEJMoa0904084, Slichter 2010 ,additional,CD012342-bbs2-0071,
CD012342-bib-0080,"Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM. ",Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomised trial, Transfusion ,2014,54,    ,['citation-journal']," Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM. Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomised trial.  Transfusion 2014;54(10):2385‐93.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/trf.12646', 'https://www.ncbi.nlm.nih.gov/pubmed/24724863', 'https://scholar.google.com/scholar_lookup?title=Impact+of+prophylactic+platelet+transfusions+on+bleeding+events+in+patients+with+hematologic+malignancies:+a+subgroup+analysis+of+a+randomised+trial+&author=SJ+Stanworth&author=LJ+Estcourt&author=CA+Llewelyn&author=MF+Murphy&author=EM+Wood&publication_year=2014&hl=en']",24724863,https://doi.org/10.1111/trf.12646, Stanworth 2014 ,additional,CD012342-bbs2-0072,
CD012342-bib-0081,"Stanworth SJ, Navarrete C, Estcourt L, Marsh J. ",Platelet refractoriness ‐ practical approaches and ongoing dilemmas in patient management, British Journal of Haematology ,2015,171,    ,['citation-journal']," Stanworth SJ, Navarrete C, Estcourt L, Marsh J. Platelet refractoriness ‐ practical approaches and ongoing dilemmas in patient management.  British Journal of Haematology 2015;171(3):297‐305.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/bjh.13597', 'https://www.ncbi.nlm.nih.gov/pubmed/26194869', 'https://scholar.google.com/scholar_lookup?title=Platelet+refractoriness+‐+practical+approaches+and+ongoing+dilemmas+in+patient+management&author=SJ+Stanworth&author=C+Navarrete&author=L+Estcourt&author=J+Marsh&publication_year=2015&hl=en']",26194869,https://doi.org/10.1111/bjh.13597, Stanworth 2015 ,additional,CD012342-bbs2-0073,
CD012342-bib-0082,"Steensma DP, Bennett JM. ",The myelodysplastic syndromes: diagnosis and treatment, Mayo Clinic Proceedings ,2006,81,    ,['citation-journal']," Steensma DP, Bennett JM. The myelodysplastic syndromes: diagnosis and treatment.  Mayo Clinic Proceedings 2006;81(1):104‐30.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.4065/81.1.104', 'https://www.ncbi.nlm.nih.gov/pubmed/16438486', 'https://scholar.google.com/scholar_lookup?title=The+myelodysplastic+syndromes:+diagnosis+and+treatment&author=DP+Steensma&author=JM+Bennett&publication_year=2006&hl=en']",16438486,https://doi.org/10.4065/81.1.104, Steensma 2006 ,additional,CD012342-bbs2-0074,
CD012342-bib-0083,"Sterne JA, Egger M, Moher D. ","Chapter 10: Addressing reporting biases. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011",,,,. Available from handbook.cochrane.org.   ,['citation-other']," Sterne JA, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.    ",[],,, Sterne 2011 ,additional,CD012342-bbs2-0075,
CD012342-bib-0084,"Sterne JA, Higgins JPT, Reeves BC on behalf of the development group for ACROBAT‐NRSI. ","A Cochrane Risk of Bias Assessment Tool: for Non‐Randomized Studies of Interventions (ACROBAT‐ NRSI), Version 1.0.0",,,,. www.riskofbias.info 2014 (accessed prior to 12 February 2016).   ,['citation-other']," Sterne JA, Higgins JPT, Reeves BC on behalf of the development group for ACROBAT‐NRSI. A Cochrane Risk of Bias Assessment Tool: for Non‐Randomized Studies of Interventions (ACROBAT‐ NRSI), Version 1.0.0. www.riskofbias.info 2014 (accessed prior to 12 February 2016).    ",[],,, Sterne 2014 ,additional,CD012342-bbs2-0076,
CD012342-bib-0085,"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. ",Practical methods for incorporating summary time‐to‐event data into meta‐analysis,,2007,,    ,['citation-other']," Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials2007; Vol. 8:16. [DOI: 10.1186/1745‐6215‐8‐16]    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Practical+methods+for+incorporating+summary+time‐to‐event+data+into+meta‐analysis&author=JF+Tierney&author=LA+Stewart&author=D+Ghersi&author=S+Burdett&author=MR+Sydes&publication_year=2007&hl=en'],,, Tierney 2007 ,additional,CD012342-bbs2-0077,
CD012342-bib-0086,"Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. ",Guideline on the investigation and management of acute transfusion reactions, British Journal of Haematology ,2012,159,    ,['citation-journal']," Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions.  British Journal of Haematology 2012;159(2):143‐53.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/bjh.12017', 'https://www.ncbi.nlm.nih.gov/pubmed/22928769', 'https://scholar.google.com/scholar_lookup?title=Guideline+on+the+investigation+and+management+of+acute+transfusion+reactions&author=H+Tinegate&author=J+Birchall&author=A+Gray&author=R+Haggas&author=E+Massey&author=D+Norfolk&publication_year=2012&hl=en']",22928769,https://doi.org/10.1111/bjh.12017, Tinegate 2012 ,additional,CD012342-bbs2-0078,
CD012342-bib-0087,The Trial to Reduce Alloimmunization to Platelets Study Group. ,Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions, New England Journal of Medicine ,1997,337,    ,['citation-journal'], The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.  New England Journal of Medicine 1997;337(26):1861‐70.    Link to article     PubMed     ,"['https://doi.org/10.1056/NEJM199712253372601', 'https://www.ncbi.nlm.nih.gov/pubmed/9417523']",9417523,https://doi.org/10.1056/NEJM199712253372601, TRAP 1997 ,additional,CD012342-bbs2-0079,
CD012342-bib-0088,"Verma A, Agarwal P. ",Platelet utilization in the developing world: strategies to optimise platelet transfusion practices, Transfusion and Apheresis Science ,2009,41,    ,['citation-journal']," Verma A, Agarwal P. Platelet utilization in the developing world: strategies to optimise platelet transfusion practices.  Transfusion and Apheresis Science 2009;41(2):145‐9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.transci.2009.07.005', 'https://www.ncbi.nlm.nih.gov/pubmed/19716339', 'https://scholar.google.com/scholar_lookup?title=Platelet+utilization+in+the+developing+world:+strategies+to+optimise+platelet+transfusion+practices+&author=A+Verma&author=P+Agarwal&publication_year=2009&hl=en']",19716339,https://doi.org/10.1016/j.transci.2009.07.005, Verma 2009 ,additional,CD012342-bbs2-0080,
CD012342-bib-0089,"Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, et al. ",Safety and cost effectiveness of a 10x109/L trigger for prophylactic platelet transfusions compared with the traditional 20x109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia, Blood ,1998,91,    ,['citation-journal']," Wandt H, Frank M, Ehninger G, Schneider C, Brack N, Daoud A, et al. Safety and cost effectiveness of a 10x109/L trigger for prophylactic platelet transfusions compared with the traditional 20x109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.  Blood 1998;91(10):3601‐6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1182/blood.V91.10.3601', 'https://www.ncbi.nlm.nih.gov/pubmed/9572994', 'https://scholar.google.com/scholar_lookup?title=Safety+and+cost+effectiveness+of+a+10x109/L+trigger+for+prophylactic+platelet+transfusions+compared+with+the+traditional+20x109/L+trigger:+a+prospective+comparative+trial+in+105+patients+with+acute+myeloid+leukemia+&author=H+Wandt&author=M+Frank&author=G+Ehninger&author=C+Schneider&author=N+Brack&author=A+Daoud&publication_year=1998&hl=en']",9572994,https://doi.org/10.1182/blood.V91.10.3601, Wandt 1998 ,additional,CD012342-bbs2-0081,
CD012342-bib-0090,World Health Organization. ,,WHO Handbook for Reporting Results of Cancer Treatment,1979,,.   ,['citation-book']," World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset publication No. 48. Geneva: World Health Organization, 1979.    ",[],,, WHO 1979 ,additional,CD012342-bbs2-0082,
CD012342-bib-0091,"Young NS, Kaufman DW. ",The epidemiology of acquired aplastic anemia, Haematologica ,2008,93,    ,['citation-journal']," Young NS, Kaufman DW. The epidemiology of acquired aplastic anemia.  Haematologica 2008;93(4):489‐92.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.3324/haematol.12855', 'https://www.ncbi.nlm.nih.gov/pubmed/18379007', 'https://scholar.google.com/scholar_lookup?title=The+epidemiology+of+acquired+aplastic+anemia&author=NS+Young&author=DW+Kaufman&publication_year=2008&hl=en']",18379007,https://doi.org/10.3324/haematol.12855, Young 2008 ,additional,CD012342-bbs2-0083,
CD012342-bib-0092,"Zeller, M. ","Chapter 18: Platelet transfusion, alloimmunization and management of platelet refractoriness",,,,. https://professionaleducation.blood.ca/en/transfusion/clinical‐guide/platelet‐transfusion‐alloimmunization‐and‐management‐platelet (accessed prior to 11 July 2017).   ,['citation-other']," Zeller, M. Chapter 18: Platelet transfusion, alloimmunization and management of platelet refractoriness. https://professionaleducation.blood.ca/en/transfusion/clinical‐guide/platelet‐transfusion‐alloimmunization‐and‐management‐platelet (accessed prior to 11 July 2017).    ",[],,, Zeller 2016 ,additional,CD012342-bbs2-0084,
CD012342-bib-0093,"Ashraf A, Hadjinicolaou AV, Doree C, Hopewell S, Trivella M, Estcourt LJ. ",Comparison of a therapeutic‐only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders, Cochrane Database of Systematic Reviews ,2016,,    ,['citation-journal']," Ashraf A, Hadjinicolaou AV, Doree C, Hopewell S, Trivella M, Estcourt LJ. Comparison of a therapeutic‐only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.  Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/14651858.CD012342]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD012342', 'https://www.ncbi.nlm.nih.gov/pubmed/27660553', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+a+therapeutic‐only+versus+prophylactic+platelet+transfusion+policy+for+people+with+congenital+or+acquired+bone+marrow+failure+disorders+&author=A+Ashraf&author=AV+Hadjinicolaou&author=C+Doree&author=S+Hopewell&author=M+Trivella&author=LJ+Estcourt&publication_year=2016&hl=en']",27660553,https://doi.org/10.1002/14651858.CD012342, Ashraf 2016 ,other_versions,CD012342-bbs2-0085,
